Today, we honor the one-year anniversary of the formation of the COVID-19 High Performance Computing Consortium, a ground-breaking public-private initiative that gives researchers around the globe unprecedented access to the world’s most powerful computing resources. The Consortium brings together 43 organizations from around the world, uniting academia, government, and technology companies – many of whom are typically rivals - to tackle COVID-19, sharing their knowledge in ways not possible if they were acting alone.
In a newly published paper “Quantitative language features identify placebo responders in chronic back pain” in the peer-reviewed journal PAIN, we report the first proof-of-concept that uses AI to analyze patients’ clinical trial experiences. The AI quantifies a placebo response in patients with chronic pain and distinguishes those who respond to placebo from those who do not.
In a new paper published in The Lancet’s EBioMedicine journal, “Evaluation of an Artificial Intelligence System for Assisting Neurologists with Fast and Accurate Annotation of Scalp Electroencephalography Data,” we describe the design and implementation of a new open hybrid cloud platform to manage and analyze secured epilepsy patient data.
In our recent paper “AutoAI-TS: AutoAI for Time Series Forecasting,” which we’ll present at ACM SIGMOD 2021, AutoAI Time Series for Watson Studio incorporates the best-performing models from all possible classes — as often there is no single technique that performs best across all datasets.
In our recent paper “An autonomous debating system,” published in Nature, we describe Project Debater’s architecture and evaluate its performance. We also offer free access for academic use to 12 of Project Debater’s underlying technologies as cloud APIs, as well as trial and licensing options for developers.
Our team has turned to AI to accelerate the design and discovery of better polymer membranes to efficiently separate carbon dioxide from flue gases — the results that we will present at the upcoming 2021 Meeting of the American Physical Society.
We're excited to once again host the QC40: Physics of Computation Conference with the MIT Endicott House in order to take a look back at the past 40 years of progress, review the state of the field today, and even look into the future to imagine where we'd like this field to go. We invite you to submit talks, watch panels, and engage with experts of quantum computing from then and now. We hope that, together, we can begin writing the next chapter of the history of quantum computing.
Paving the way to the era of Accelerated Discovery, our IBM Research team has developed an AI system that can help speed up the design of molecules for novel antibiotics. In a recent Nature Biomedical Engineering paper, we outline how we used it to create two new non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency. Our approach outperforms other leading de novo AMP design methods by nearly 10 percent.
IBM researchers in Japan launch the IBM Molecule Generation Experience, a tool that accelerates new materials design with AI and Hybrid Cloud.
IBM's Charu Aggarwal earns the 2021 IEEE W. Wallace McDowell Award in recognition of his extensive body of work, particularly in the areas of high-dimensional data analysis, data stream research and data privacy techniques. The W. Wallace McDowell Award, referred to as the "IT Nobel," is named after the former director of engineering at IBM during the development of the pioneering IBM 701 electronic data processing machine in the early 1950s.
In order to create a culture and climate within and outside of IBM Research that embraces, supports, and enables successful careers in STEM, we need to work together every day to hire, empower, and grow women in STEM fields.